Skip to main content

Scienture Holdings, Inc.

SCNX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001382574

No open-market purchases or sales by Scienture Holdings, Inc. insiders were filed in the last 90 days; 15 institutions reported holding it in 13F filings for Q2 2026, worth $709.1K in total; no superinvestor holds it.

Q2 2023 vs. Q1 2023

How the institutions holding Scienture Holdings, Inc. changed between Q1 2023 and Q2 2023.

All holders in Q2 2023All holders in Q1 2023

13F holders of SCNX: Q1 2023 compared with Q2 2023
MeasureQ1 2023Q2 2023Change
Holders128−4
Shares236.4K28.0K−208.4K (−88.1%)
Value$69.2K$298.2K+$229.0K (+330.7%)

New holders (4)

Institutions that held Scienture Holdings, Inc. at the end of Q2 2023 but not at the end of Q1 2023.

Institutions new to SCNX in Q2 2023
InstitutionSharesValue% of portfolio
Morgan Stanley13,867$181.0K0.00%
Barclays PLC4,801$62.7K0.00%
UBS Group AG900$11.7K0.00%
JPMorgan Chase & Co884$11.5K0.00%

Sold out (8)

Institutions that held Scienture Holdings, Inc. at the end of Q1 2023 and filed for Q2 2023 without it.

Institutions that sold out of SCNX in Q2 2023
InstitutionShares, Q1 2023Value, Q1 2023
National Asset Management, Inc.48,278$14.2K
Geode Capital Management, LLC42,057$12.4K
Vanguard Group Inc39,629$11.7K
Wealth Dimensions Group, Ltd.30,979$9.14K
Virtu Financial LLC25,111$7.00K
Susquehanna International Group, LLP19,580$5.78K
Citigroup Inc4,169$1.23K
Spire Wealth Management2,458$738